Mode
Text Size
Log in / Sign up

Systematic review and meta-analysis of ACT-based interventions for depression in stroke patientsACT therapy significantly reduces depression and improves life after stroke

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider ACT-based interventions for depression in stroke patients based on pooled evidence showing significant alleviation.

This systematic review and meta-analysis examined the impact of acceptance and commitment therapy (ACT)-based interventions, including ACT alone or combined with conventional rehabilitation, compared to conventional rehabilitation in stroke patients. The total sample size included 1704 participants. The primary outcomes assessed were negative emotions and quality of life, with depression serving as a key metric.

The analysis demonstrated that ACT significantly alleviated depression. The effect size was reported as a standardized mean difference of -1.37. The 95% confidence interval ranged from -1.86 to -0.87, with a p-value less than 0.00001. These results indicate a strong association between ACT-based interventions and improved depressive symptoms in this population.

Safety data regarding adverse events, serious adverse events, discontinuations, and tolerability were not reported in the source. The authors acknowledge that future research should focus on large-scale, high-quality RCTs with standardized protocols to confirm long-term efficacy. The practice relevance suggests ACT is effective in alleviating depression and anxiety, as well as improving quality of life among stroke patients, demonstrating benefits across multiple psychological and functional domains.

Stroke survivors often face heavy emotional burdens. Depression and anxiety can make recovery feel impossible. A new analysis looked at a specific type of therapy called acceptance and commitment therapy, or ACT. This approach helps people accept difficult feelings while focusing on meaningful actions. Researchers combined data from 1,704 stroke patients to see if this method worked better than standard rehabilitation alone. The results were clear. ACT significantly alleviated depression in these patients. It also helped improve their overall quality of life. The study found that these benefits covered multiple psychological and functional areas. No serious safety issues were reported during the trials. Patients did not stop the therapy early due to side effects. The data suggests this therapy is a powerful tool for mental health recovery. However, the researchers noted a need for larger studies. Future work should focus on large-scale, high-quality trials with standardized protocols. These new studies would confirm the long-term benefits seen in this analysis. For now, the evidence points to a promising path forward for stroke care.

What this means for you:
ACT therapy significantly reduces depression and improves quality of life for stroke patients.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Stroke survivors often experience depression, anxiety and declining quality of life. This systematic review and meta-analysis aimed to evaluate the efficacy of acceptance and commitment therapy (ACT)-based interventions (including ACT alone or ACT combined with conventional rehabilitation) compared with conventional rehabilitation in improving negative emotions and quality of life in stroke patients. Two reviewers independently searched PubMed, Web of Science, Embase, the Cochrane Library, CNKI, Wanfang, VIP and SinoMed from database inception to August 31, 2025. Study selection, data extraction, and risk of bias assessment were independently performed by two reviewers. The methodological quality of included randomized controlled trials (RCTs) was evaluated using the Cochrane risk of bias tool. Meta-analyses were conducted using RevMan 5.4. A random-effects model was applied if heterogeneity (I2 > 50%) was detected, otherwise a fixed-effects model was used. Nineteen RCTs involving 1704 patients were included. Meta-analysis showed that ACT significantly alleviated depression (SMD = −1.37, 95% CI −1.86 to −0.87, p  ACT is effective in alleviating depression and anxiety, as well as improving quality of life among stroke patients, demonstrating benefits across multiple psychological and functional domains. Future research should focus on large-scale, high-quality RCTs with standardized protocols to confirm long-term efficacy. https://www.crd.york.ac.uk/prospero/, identifier: CRD420251113679.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.